Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ningmitai is a Traditional Chinese Medicine (TCM) capsule developed and manufactured by Guiyang Xintian Pharmaceutical. It is a multi-herbal formulation traditionally used to treat damp-heat conditions of the urinary system. Its primary indications include urinary tract infections, pyelonephritis, and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The capsule is also used as an adjunct therapy to facilitate the passage of residual stone fragments after lithotripsy and to alleviate lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The therapeutic effects are attributed to its anti-inflammatory, antibacterial, and diuretic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ningmitai.